Venture Capital

The diabetes tech firm secures major funding for innovation and acquisitions, using a savvy financial strategy to protect current shareholder value.

A new tech startup is launching an AI platform to replace high-pressure sales with transparent pricing, promising to cut homeowners' roof costs by up to 50%.

Promising trial data for onvansertib offers new hope for colorectal cancer patients, yet leadership changes and financial hurdles cloud the path forward.

Navitas Semiconductor accepts short-term losses for a future in AI data centers and energy, signaling a major shift in the power electronics landscape.

Following strong Q4 earnings, Datadog will detail its AI and cloud strategy at a major conference, with investors and tech leaders watching closely.

After a major trial miss sent its stock tumbling, GRAIL will face investors to pitch its vision for the future of early cancer detection technology.

Pioneering clean beauty brand Indie Lee launches an affordable new line, Indie Lee Botanicals, exclusively at Whole Foods Market, making quality skincare accessible.

With $6.9M in total funding, the UMass spin-out is set to disrupt AR and AI markets with its durable, all-inorganic nano-imprinted optical components.

With new backing from One Six 8 Ventures, health tech firm Respiree accelerates its US and Canadian expansion of its FDA-cleared AI platform.

With new high-protein flavors, Forager Project is betting on a unique cashew-based recipe to win over consumers disappointed by other dairy-free options.

As smugglers take to the sea in high-tech subs, companies like Jeffs' Brands are betting on AI-driven underwater security to turn the tide.

With 43% YoY growth, Cato Networks is outpacing the SASE market. A new acquisition and key hires signal a deep focus on securing the AI era.

Kenai Therapeutics hires a Novartis M&A veteran as CBO, signaling an aggressive strategy to advance its groundbreaking iPSC cell therapy for Parkinson's disease.

Fastest-growing US professional skincare brand HYDRINITY partners with VeraSeaCosmetics, bringing its regenerative science to France's $5.4B beauty scene.

Emerald Cruises names two employees as godparents for its new yacht, Emerald Kaia, signaling a major fleet expansion and a new era of intimate luxury cruising.

With a new CRO and a major retail push, can the values-led organic drink company replicate its foodservice success against CPG giants? We investigate.

A major state investment at Oklahoma State University is set to transform the local food industry, promising safer, fresher products and economic growth.

As the Milano Cortina 2026 Games close, a look at how specialized online academies are revolutionizing training for elite student-athletes.

With a massive Series A, Alveus Therapeutics is advancing novel drugs aiming for more durable and higher-quality weight loss than current blockbusters.

Dr. Frank Smith joins XenoSTART to lead its preclinical unit, aiming to leverage its vast patient-derived model library to speed up oncology drug development.